China Zhifei’s COVID vaccine largely works on delta variant: study – Nikkei Asia

BEIJING (Reuters) — A COVID-19 vaccine developed by a unit of China’s Chongqing Zhifei Biological Products largely retained its neutralising effect against the Delta variant but there was a slight reduction, Chinese researchers found in a laboratory study.
…

Click here to view the original article.